The Cost of Juvenile-Onset Recurrent Respiratory Papillomatosis
Open Access
- 1 August 2000
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 126 (8) , 935-939
- https://doi.org/10.1001/archotol.126.8.935
Abstract
JUVENILE-ONSET recurrent respiratory papillomatosis (JORRP) is a condition with an incidence rate of 0.4 to 1.2 cases per 100,000 person-years1 that afflicts roughly 254 to 763 US children each year. Children with JORRP must undergo repeated costly treatments to reduce the size of recurrent warty lesions in the upper airway. The disease places a heavy burden on families who are often ill-equipped to cope with it.Keywords
This publication has 6 references indexed in Scilit:
- Initial Results From the National Registry for Juvenile-Onset Recurrent Respiratory PapillomatosisJAMA Otolaryngology–Head & Neck Surgery, 1999
- Maternal minimum-stay legislation: cost and policy implications.American Journal of Public Health, 1999
- Risk factors for juvenile onset recurrent respiratory papillomatosisThe Pediatric Infectious Disease Journal, 1998
- Valuing morbidity: An integration of the willingness-to-pay and health-status index literaturesJournal of Health Economics, 1997
- Epidemiology of Genital Human Papillomavirus InfectionThe American Journal of Medicine, 1997
- The International Classification of Diseases: Ninth Revision (ICD-9)Annals of Internal Medicine, 1978